![](/img/cover-not-exists.png)
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Tomiak, E, Piccart, M J, Kerger, J, Lips, S, Awada, A, de Valeriola, D, Ravoet, C, Lossignol, D, Sculier, J P, Auzannet, VVolume:
12
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1994.12.7.1458
Date:
July, 1994
File:
PDF, 837 KB
1994